The lawsuit now targets 18 manufacturers of generic drugs and two executives. Read more
Sanofi will get $38.7 million of the total settlement as a whistleblower award. Read more
The recalled injectors were manufactured for Mylan by Pfizer’s Meridian Medical Technologies. Read more
Price fixing and market allocation are illegal and violate antitrust laws. Read more
Mylan added that EpiPen has been classified as a generic since before it acquired the product in 2007. Read more
Mylan hasn’t garnered any sympathy, particularly in light of news that its top leaders who have enjoyed huge salary bumps during the same period that EpiPen’s price skyrocketed. Read more
Agila Specialties Private Limited, a subsidiary of Mylan Inc., has recalled the hospital/user level of 10 lots of Etomidate Injection 2 mg/mL – 10 mL and 20 mL (see lot breakdown below). The... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.